Author

L. Munoz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:clinical cohort / trial· 1 Organism:E. coli· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Lopez Casanello· 1 shared A. O'Neill· 1 shared A. Pustilnik· 1 shared A. Suarez· 1 shared A. Tamborini· 1 shared B. A. Heinz· 1 shared C. A. Cohen· 1 shared C. Pritchard· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Lopez Casanello

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

K. Westendorf, S. Zentelis, L. Wang, D. Foster, P. Vaillancourt, M. Wiggin, E. Lovett, R. van der Lee, J. Hendle, A. Pustilnik, J. M. Sauder, L. Kraft, Y. Hwang, R. W. Siegel, J. Chen, , Ramamurt

This paper identifies LY-CoV1404, a potent SARS-CoV-2 neutralizing antibody effective against multiple variants, including Omicron and Delta, due to its conserved epitope and resistance to common mutations.

bioRxiv · Apr 30, 2021Immunology

Surveillance of Shiga toxin-producing Escherichia coli associated bloody diarrhea in Argentina

M. Rivas, M. Pichel, M. Colonna, A. Lopez Casanello, L. Alconcher, J. Galavotti, I. Prinicipi, S. Perez Araujo, F. B. Ramirez, G. Gonzalez, L. Pianciola, M. Mazzeo, A. Suarez, S. Oderiz, L. F. Ghezzi, , E. TEAM

The paper investigates STEC-associated bloody diarrhea and progression to HUS in children in Argentina, finding 4.1% STEC-positive cases and 13.8% progressing to HUS.

bioRxiv · Jan 7, 2021Microbiology